First report of successful treatment for hemoglobin Bristol-Alesha by hemopoietic stem cell transplantation.

Shanshan Li, Kai Chen, Can Huang, Na Zhang, Hui Jiang, Shayi Jiang

Annals of hematology 2022 Mar

filter terms:

HBB gene mutations lead to many kinds of diseases, of which, except for the two most common diseases of thalassemia and sickle cell anemia, rare kinds of hemolytic anemia, such as hemoglobin Bristol-Alesha, are rarely reported, no ideal treatment in clinic. A child suffered from chronic recurrent hemolytic attacks and the related genes of hereditary hemolytic anemia were detected on her. Hematopoietic stem cell transplantation was conducted in the treatment of the patient. The patient was diagnosed as hemoglobin Bristol-Alesha and achieved complete recovery after hematopoietic stem cell transplantation. For Bristol-Alesha, without characteristic clinical manifestation and specific biochemical examination, diagnosis is dependent on the gene mutation detection and hematopoietic stem cell transplantation is an effective and curable method. © 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Citation

Shanshan Li, Kai Chen, Can Huang, Na Zhang, Hui Jiang, Shayi Jiang. First report of successful treatment for hemoglobin Bristol-Alesha by hemopoietic stem cell transplantation. Annals of hematology. 2022 Mar;101(3):617-619